Y Lebranchu

1.4k total citations
39 papers, 790 citations indexed

About

Y Lebranchu is a scholar working on Transplantation, Surgery and Oncology. According to data from OpenAlex, Y Lebranchu has authored 39 papers receiving a total of 790 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Transplantation, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Y Lebranchu's work include Renal Transplantation Outcomes and Treatments (9 papers), Cell Adhesion Molecules Research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). Y Lebranchu is often cited by papers focused on Renal Transplantation Outcomes and Treatments (9 papers), Cell Adhesion Molecules Research (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). Y Lebranchu collaborates with scholars based in France, Germany and United Kingdom. Y Lebranchu's co-authors include Ajit P. Limaye, Daniel Abramowicz, Patrick Peeters, Emily A. Blumberg, Jeffrey D. Punch, Alan G. Jardine, Atul Humar, Flavio Vincenti, J. Ives and I.A. Hauser and has published in prestigious journals such as The Journal of Immunology, Transplantation and American Journal of Transplantation.

In The Last Decade

Y Lebranchu

37 papers receiving 766 citations

Peers

Y Lebranchu

EPIDE

TRANS

ONCOL

IMMUN

PMH

D Conti United States

R. D. C. Forbes Canada

Hervé Betuel France

James Pattison United Kingdom

Corinne Antoine France

B. Demirhan Türkiye

Tirza Klein Israel

Maxime Touzot France

Jared Klein United States

H. Noreen United States

D Conti United States

Y Lebranchu

226 ×0.5

EPIDE

161 ×1.0

TRANS

170 ×1.4

ONCOL

182 ×1.6

IMMUN

85 ×0.8

PMH

Citations per year, relative to Y Lebranchu Y Lebranchu (= 1×) peers D Conti

Countries citing papers authored by Y Lebranchu

Since Specialization

Citations

This map shows the geographic impact of Y Lebranchu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Lebranchu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Lebranchu more than expected).

Fields of papers citing papers by Y Lebranchu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Lebranchu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Lebranchu. The network helps show where Y Lebranchu may publish in the future.

Co-authorship network of co-authors of Y Lebranchu

This figure shows the co-authorship network connecting the top 25 collaborators of Y Lebranchu. A scholar is included among the top collaborators of Y Lebranchu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Lebranchu. Y Lebranchu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gatault, Philippe, Mathilde Boulanger, Jean‐Luc Taupin, et al.. (2011). Mothers without HLA antibodies before transplantation have a low risk of alloimmunization post‐transplantation. Tissue Antigens. 78(4). 241–248. 6 indexed citations

Vuiblet, Vincent, Philippe Birembaut, Abel François, et al.. (2011). Sirolimus-based regimen is associated with decreased expression of glomerular vascular endothelial growth factor. Nephrology Dialysis Transplantation. 27(1). 411–416. 8 indexed citations

Humar, Atul, Y Lebranchu, Flavio Vincenti, et al.. (2010). The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients. American Journal of Transplantation. 10(5). 1228–1237. 366 indexed citations

Martinez, F., Nassim Kamar, Nicolas Pallet, et al.. (2010). High Dose Epoetin Beta in the First Weeks Following Renal Transplantation and Delayed Graft Function: Results of the Neo‐PDGF Study. American Journal of Transplantation. 10(7). 1704–1709. 59 indexed citations

Humar, Abhi, Y Lebranchu, Flavio Vincenti, et al.. (2009). The IMPACT Study: Valganciclovir Prophylaxis for until 200 Days Post-Transplant in High Risk Kidney Recipients Substantially Reduces the Incidence of CMV Disease.. Ghent University Academic Bibliography (Ghent University). 10 indexed citations

Kliem, Volker, Michael Burg, B. Dussol, et al.. (2009). Geographical prevalence, risk factors and impact of hepatitis B and C after renal transplantation. Clinical Nephrology. 71(4). 423–429. 9 indexed citations

Hoffmann, Thomas, Jean‐Michel Halimi, Matthias Büchler, et al.. (2009). Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation. Journal of Medical Genetics. 47(1). 54–58. 38 indexed citations

Étienne, Isabelle, P. Le Pogamp, Frank Bridoux, et al.. (2006). Long-Term Results of Monoclonal Anti-Il2-Receptor Antibody Versus Polyclonal Antilymphocyte Antibodies as Induction Therapy in Renal Transplantation. Transplantation Proceedings. 38(7). 2298–2299. 22 indexed citations

Lebranchu, Y, et al.. (2005). Neuromyopathie toxique induite par la ciclosporine. Revue Neurologique. 161(2). 221–223.

10.

Thibault, Gilles, et al.. (2000). Induction of Jurkat T-cell apoptosis by Fas ligand-transfected endothelial cells. Transplantation Proceedings. 32(8). 2737–2738. 2 indexed citations

11.

Büchler, M.W., et al.. (1999). Infection par le virus BK chez un transplanté rénal. Virologie. 3(5). 418–419. 2 indexed citations

12.

Reverdiau, Pascale, et al.. (1996). Comparative study of porcine and human blood coagulation systems: possible relevance in xenotransplantation.. PubMed. 28(2). 643–4. 18 indexed citations

13.

Büchler, M., et al.. (1995). Posttransplant anti-HLA antibodies: risk factor for chronic rejection?. PubMed. 27(4). 2478–9. 4 indexed citations

14.

Lebranchu, Y, et al.. (1994). Soluble e-selectin, ICAM-1, and VCAM-1 levels in renal allograft recipients.. PubMed. 26(4). 1873–4. 6 indexed citations

15.

Durand, Isabelle, G Blaysat, Sylvain Chauvaud, et al.. (1993). [Extensive fibrous endocarditis as first manifestation of systemic lupus erythematosus].. PubMed. 50(8). 685–8. 3 indexed citations

16.

Galéa, Pascale & Y Lebranchu. (1992). [Adhesion of lymphocytes to allogenic endothelium. Four different pathways].. PubMed. 21(41). 1968–70. 1 indexed citations

17.

Nivet, Hubert, et al.. (1980). [Bartter's syndrome: seven cases in siblings. Hypothesis of mild forms (author's transl)].. PubMed. 9(18). 1287–90. 3 indexed citations

18.

Buriot, D, et al.. (1979). [Acute leukemia in 3 children with chronic juvenile arthritis treated with chlorambucil].. PubMed. 36(6). 592–8. 7 indexed citations

19.

Lebranchu, Y, et al.. (1978). [Congenital tracheobiliary fistula. Report of a case with choledocal hypoplasia (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 19(3). 189–95. 2 indexed citations

20.

Lebranchu, Y, et al.. (1976). Un cas de syndrome de défibrination chez un nourrisson présentant une intolérance héréditaire au fructose. 31(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact